Ocular Therapeutix OCUL
NASDAQ OCUL
$7.66 -1.99 (-20.67%)
At close: Sep 28, 2026 · 4:00 PM EDT

Ocular Therapeutix (OCUL) Total Non-Current Liabilities (2013 - 2026)

Updated

Ocular Therapeutix (OCUL) recorded Total Non-Current Liabilities of $140.37 million in Q2 2026, up 6.8% from $131.39 million a year earlier and up 1.1% from the prior quarter.

Analysis

Ocular Therapeutix (OCUL) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

At the end of FY2025, Ocular Therapeutix reported Total Non-Current Liabilities of $139.84 million, up 8.1% from FY2024.

  • Annual Total Non-Current Liabilities has a five-year compound annual growth rate of 9.8% (FY2020 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $129.35 million in FY2024 (-1.2%), $130.94 million in FY2023 (+21.7%), $107.56 million in FY2022 (+11.2%) and $96.7 million in FY2021 (+10.6%).
  • The Q2 2026 figure is the highest quarterly Total Non-Current Liabilities in data going back to Q4 2013.
  • On a year-over-year basis, Total Non-Current Liabilities has increased for six consecutive quarters, with growth averaging 6.9% over the last eight quarters.
  • Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 29.5% in Q3 2023, against a decline of 5.1% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $138.88 million (Q1 2026), $139.84 million (Q4 2025) and $137.69 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 105.99 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 106.45 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -967.00 Mn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 5.92 Bn
10 Ocular Therapeutix 2.12 Bn 2.12 Bn 11.46 Mn 140.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 140.37 Mn
Mar 31, 2026 138.88 Mn
Dec 31, 2025 139.84 Mn
Sep 30, 2025 137.69 Mn
Jun 30, 2025 131.39 Mn
Mar 31, 2025 126.14 Mn
Dec 31, 2024 129.35 Mn
Sep 30, 2024 123.88 Mn
Jun 30, 2024 117.32 Mn
Mar 31, 2024 111.34 Mn
Dec 31, 2023 130.94 Mn
Sep 30, 2023 130.51 Mn
Jun 30, 2023 107.69 Mn
Mar 31, 2023 105.95 Mn
Dec 31, 2022 107.56 Mn
Sep 30, 2022 100.76 Mn
Jun 30, 2022 96.81 Mn
Mar 31, 2022 94.59 Mn
Dec 31, 2021 96.70 Mn
Sep 30, 2021 94.34 Mn
API Access

Ocular Therapeutix Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=OCUL&period=max&api_key=YOUR_API_KEY